Elsevier logo

Publisher: Elsevier

Volume 8, Number 3, 1 March 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Fly-ing from genes to drugs
pp. 99-101(3)
Author: Chan H.Y.E.

Functions of the fragile X protein
pp. 102-103(2)
Author: Oostra B.A.

Hijacking of key signaling pathways by H. pylori
pp. 106-106(1)
Author: Ward S.

Fusion protein delays Wallerian degeneration
pp. 106-107(2)
Author: Hafezparast M.

In Brief
pp. 107-108(2)
Authors: Weitzman J.; O'Neill P.

Microchimerism: incidental byproduct of pregnancy or active participant in human health?
pp. 109-113(5)
Author: Nelson J.L.

Medicinal chemistry and therapeutic potential of CpG DNA
pp. 114-121(8)
Authors: Agrawal S.; Kandimalla E.R.

New immunotherapeutic strategies to control vaginal candidiasis
pp. 121-126(6)
Authors: Magliani W.; Conti S.; Cassone A.; De Bernardis F.; Polonelli L.

Glycogen synthase kinase 3: an emerging therapeutic target
pp. 126-132(7)
Author: Eldar-Finkelman H.

Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans
pp. 133-139(7)
Authors: van Bokhoven H.; McKeon F.

Disease model: Fanconi anemia
pp. 139-142(4)
Authors: Wong J.C.Y.; Buchwald M.

Embryo and stem cell research in the USA: a political history
pp. 143-146(4)
Author: Wertz D.C.

Salvation through science
pp. 146-147(2)
Author: Ashcroft R.

Prions updated
pp. 147-147(1)
Author: Ironside J.W.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A